Zepbound, the obesity-indication version of tirzepatide, added $5.7 billion in H1 2025, a product that was not launched until late 2023 and is now available in a multi-dose KwikPen
Its a pretty nice dashboard, but like I mentioned, its run by Practice Better, which appears to be a platform that contracts out to providers like Zappy who need an all-in-one solution for telehealth
Patients who have been on semaglutide for a long time but have suddenly started experiencing cramps should not ignore these symptoms, as they could indicate a need for further medical evaluation
To support this, its essential to choose foods that keep your blood sugar stable
By Patrick Wingrove (Reuters) -Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ahead of the timeline set out with the Trump administration